pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 11·1 min read
save

Experts warn splitting MMR vaccine into separate shots could increase missed doses and illness

Aug 11, 2026·read at STAT ↗RegulatoryNegative

The article notes that a recent executive order proposes separating the combined measles, mumps and rubella vaccine into three individual injections. The author argues that this change could lead to more children missing doses, raising the risk of disease outbreaks.

He cites the history of the MMR vaccine’s development, recalling how the original combined formulation was created after a child’s mumps infection was studied by a Merck scientist. The piece emphasizes that the combined shot has been proven safe and effective.

The author warns that forcing manufacturers to produce separate vaccines may create logistical challenges and reduce vaccination rates, ultimately harming public health.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “How we know that splitting up the MMR vaccine could be dangerous”

read at STAT ↗
1,135 words · retrieved Aug 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING
topics
Vaccine19Vaccines14Breast CancerImmunologyInfectious DiseaseOncology

related stories

  • 8h agoNovo workforce down 13,000BioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: Sling reels in $123M; Circle gathers $92.5MFierce Biotech
  • Sep 1Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?Fierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Apr 28Predicting consequences of new hepatitis B vaccine recsSTAT